Jan 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Allogene Therapeutics, Blackstone and Planet Labs Pbc, on Tuesday. HIGHLIGHTS * Allogene Therapeutics Inc : JP Morgan raises to overweight from neutral * Blackstone Inc : JP Morgan raises to overweight from neutral * Planet Labs Pbc : Morgan Stanley starts coverage with equal weight rating Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order. * 1st Source Corp : Piper Sandler cuts target price to $58 from $64 * Advanced Micro Devices Inc : Bernstein cuts to market-perform from outperform * Advanced Micro Devices Inc : Bernstein cuts target price to $80 from $95 * Allogene Therapeutics Inc : JP Morgan cuts target price to $11 from $20 * Allogene Therapeutics Inc : JP Morgan raises to overweight from neutral * Ally Financial Inc : Goldman Sachs raises target price to $36 from $28 * American Electric Power Company Inc : JP Morgan cuts target price to $105 from $106 * Ameriprise Financial Inc : RBC raises target price to $360 from $350 * Baker Hughes Co : Atb Capital Markets cuts target price to $38 from $39 * Baker Hughes Co : Evercore ISI raises target price to $37 from $33 * Baker Hughes Co : RBC raises target price to $35 from $33 * Banc of California Inc : Stephens raises target price to $19 from $18 * Bank of Marin Bancorp : Piper Sandler cuts target price to $34 from $35 * Banner Corp : Stephens raises target price to $75 from $73 * Blackstone Inc : JP Morgan raises to overweight from neutral * Blackstone Inc : JP Morgan raises target price to $105 from $104 * Brunswick Corp : Jefferies cuts target price to $95 from $100 * Bumble Inc : Jefferies raises target price to $22 from $18 * Burlington Stores Inc : Jefferies raises target price to $260 from $225 * Carlyle Group Inc : JP Morgan raises target price to $46 from $41 * Catalent Inc : Jefferies raises target price to $67 from $65 * CBOE Global Markets Inc : Credit Suisse cuts target price to $143 from $144 * Chord Energy Corp : RBC cuts target price to $190 from $195 * Citizens Community Bancorp Inc : Piper Sandler cuts target price to $13 from $14 * CME Group Inc : Credit Suisse raises target price to $192 from $191 * Comerica Inc : Goldman Sachs raises target price to $85 from $75 * Comerica Inc : Jefferies raises target price to $82 from $77 * Discover Financial Services : Evercore ISI raises target price to $117 from $105 * Evoqua Water Technologies Corp : Stifel raises target price to $54 from $49 * Federated Hermes Inc : RBC raises target price to $37 from $35 * Fifth Third Bancorp : Jefferies raises target price to $41 from $40 * Huntington Bancshares Inc : Jefferies raises target price to $14 from $13 * Inter Parfums Inc : Piper Sandler raises target price to $130 from $118 * Invesco Ltd : RBC raises target price to $19 from $17 * Iovance Biotherapeutics Inc : Truist Securities raises target price to $17 from $16 * Iqvia Holdings Inc : Jefferies raises target price to $265 from $251 * Keycorp : D.A. Davidson cuts target price to $19 from $20 * Lattice Semiconductor Corp : Cowen and Company raises target price to $87 from $78 * Luminar : JP Morgan cuts target price to $15 from $16 * M&T Bank Corp : Jefferies raises target price to $160 from $156 * Marketaxess Holdings Inc : Credit Suisse raises target price to $313 from $294 * Match Group Inc : Jefferies raises target price to $65 from $60 * Medpace Holdings Inc : Jefferies raises target price to $217 from $200 * Monolithic Power Systems Inc : Cowen and Company raises target to $490 from $425 * Planet Labs Pbc : Morgan Stanley starts coverage with equal weight rating * Pliant Therapeutics Inc : JP Morgan raises target price to $51 from $42 * Pliant Therapeutics Inc : Needham raises target price to $45 from $40 * Pliant Therapeutics Inc : SVB Securities raises target price to $45 from $33 * Polaris Inc : Jefferies cuts target price to $105 from $106 * Potlatchdeltic Corp : D.A. Davidson cuts target price to $55 from $57 * PPG Industries Inc : Baird raises target price to $150 from $125 * PPG Industries Inc : RBC raises target price to $133 from $129 * Prologis Inc : Baird raises target price to $125 from $123 * Regions Financial Corp : Goldman Sachs raises target price to $27 from $25 * Regions Financial Corp : Jefferies raises target price to $23 from $21 * Servisfirst Bancshares Inc : Piper Sandler cuts target price to $67 from $72 * Sumo Logic Inc : Jefferies raises target price to $11 from $8.5 * Synchrony Financial : Credit Suisse cuts target price to $37 from $38 * Synchrony Financial : JP Morgan raises target price to $37 from $36 * Synchrony Financial : Piper Sandler cuts target price to $40 from $41 * target Corp : Oppenheimer starts coverage with outperform rating; target price $190 * Taysha Gene Therapies Inc : Baird cuts target price to $10 from $21 * TPG Inc : JP Morgan cuts to neutral from overweight; cuts target to $34 from $35 * Travelers Companies Inc : Credit Suisse raises target price to $199 from $178 * Warner Music Group Corp : Jefferies cuts target price to $41 from $44 * Wayfair Inc : Stephens raises target price to $48 from $45 * West Pharmaceutical Services Inc : Jefferies raises target price to $240 from $206 * Xylem Inc : Stifel raises to buy from hold; raises target price to $124 from $115 * Zions Bancorporation Na : Jefferies raises target price to $61 from $58 * Zions Bancorporation Na : RBC cuts target price to $58 from $59 (Compiled by Bengaluru Newsroom)
U.S. RESEARCH ROUNDUP-Allogene Therapeutics, Blackstone, Planet Labs Pbc


Disclaimer
The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.